Low serum free triiodothyronine levels are associated with the presence and severity of coronary artery disease in the euthyroid patients: An observational study;Ötiroid hastalarda düşük serum FT3 düzeyleri koroner arter hastalıǧının varlıǧı ve şiddeti ile ilişkilidir: Gözlemsel bir çalışma

Anadolu Kardiyoloji Dergisi

Volumn 12, Issue 7, 2012, Pages 591-596

  Ertaş, Faruk ^a   Kaya, Hasan ^a   Soydinç, Mehmet Serdar ^a  

^a DICLE UNIVERSITY   (Turkey)

Author keywords

Coronary artery disease; Gensini score; Regression analysis; Sensitivity; Specificity; Thyroid hormone levels

Indexed keywords

BIOLOGICAL MARKER; LIOTHYRONINE; THYROTROPIN; THYROXINE;

ADULT; AGED; ANGIOCARDIOGRAPHY; BLOOD; CORONARY ARTERY DISEASE; FEMALE; HUMAN; HYPOTHYROIDISM; MALE; MIDDLE AGED; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; THYROID FUNCTION TEST; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; FEMALE; HUMANS; HYPOTHYROIDISM; MALE; MIDDLE AGED; ROC CURVE; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; THYROID FUNCTION TESTS; THYROTROPIN; THYROXINE; TRIIODOTHYRONINE;

EID: 84868283885     PISSN: 13028723     EISSN: None     Source Type: Journal    
DOI: 10.5152/akd.2012.187     Document Type: Article

References (23)

1. Klein I, Ojamaa K. Thyroid hormone and the cardiovascular system. N Engl J Med 2001; 344: 501-509. [CrossRef]
2. Polikar R, Burger AG, Scherrer U, Nicod P. The thyroid and the heart. Circulation 1993;87:1435-1441. [CrossRef]
3. Roffi M, Cattaneo F, Brandle M. Thyrotoxicosis and the cardiovascular system. Minerva Endocrinol 2005; 30: 47-58.
4. Woeber KA. Thyrotoxicosis and the heart. N Engl J Med 1992; 327: 94-98. [CrossRef]
5. Biondi B, Klein I. Hypothyroidism as a risk factor for cardiovascular disease. Endocrine 2004; 24: 1-13. [CrossRef]
6. Cappola AR, Ladenson PW Hypothyroidism and atherosclerosis. J Clin Endocrinol Metab 2003; 88: 2438-2444. [CrossRef]
7. Tatar E, Kircelli F, Asci G, Carrero JJ, Güngör O, Demirci MS, et al. Associations of triiodothyronine levels with carotid atherosclerosis and arterial stiffness in hemodialysis patients. Clin J Am Soc Nephrol 2011; 9: 2240-2246. [CrossRef]
8. Peters A, Ehlers M, Blank B, Exler D, Falk C, Kohlmann T, et al. Excess triiodothyronine as a risk factor of coronary events. Arch Intern Med 2000; 13: 1993-1999. [CrossRef]
9. Bergeron GA, Goldsmith R, Schiller NB. Myocardial infarction, severe reversible ischemia, and shock following excess thyroid administration in a woman with normal coronary arteries. Arch Intern Med 1988; 148: 1450-1453. [CrossRef]
10. Auer J, Berent R, Weber T, Lassnig E, Eber B. Thyroid function is associated with presence and severity of coronary atherosclerosis. Clin Cardiol 2003; 12: 569-573. [CrossRef]
11. Yun KH, Jeong MH, Oh SK, Lee EM, Lee J, Rhee SJ. Relationship of thyroid stimulating hormone with coronary atherosclerosis in angina patients. Int J Cardiol 2007; 122: 56-60. [CrossRef]
12. Judkins MP. Selective coronary arteriography. I. A percutaneous transfemoral technique. Radiology 1967; 89:815-824.
13. Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol 1983; 51: 606. [CrossRef]
14. Oishi Y, Wakatsuki T, Nishikado A. Circulating adhesion molecules and severity of coronary atherosclerosis. Coron Artery Dis 2000; 11:77-81. [CrossRef]
15. Boelen A, Kwakkel J, Fliers E. Beyond low plasma T3: local thyroid hormone metabolism during inflammation and infection. Endocr Rev 2011; 32: 670-693. [CrossRef]
16. Berker D, Işik S, Canbay A, Aydin Y, Tütüncü Y, Delibaşi T, et al. Comparison of antithyroid drugs efficacy on P wave changes in patients with Graves' disease. Anadolu Kardiyol Derg 2009; 9: 298-303.
17. Ishikawa T, Chijiwa T, Hagiwara M, Mamiya S, Hidaka H. Thyroid hormones directly interact with vascular smooth muscle strips. Mol Pharmacol 1989; 6: 760-765.
18. Mamiya S, Hagiwara M, Inoue S, Hidaka H. Thyroid hormones inhibit platelet function and myosin light chain kinase. J Biol Chem 1989; 15: 8575-8579.
19. Költringer P, Eber O, Wakonig P, Klima G, Lind P. Hypothyroidism and the influence on human blood rheology. J Endocrinol Invest 1988; 4: 267-272.
20. Chadarevian R, Bruckert E, Ankri A, Beucler I, Giral P, Turpin G. Relationship between thyroid hormones and plasma D-dimer levels. Thromb Haemost. 1998; 1: 99-103.
21. Luboshitzky R, Aviv A, Herer P, Lavie L. Risk factors for cardiovascular disease in women with subclinical hypothyroidism. Thyroid 2002; 5: 421-425. [CrossRef]
22. Coceani M, Iervasi G, Pingitore A, Carpeggiani C, L'Abbate A. Thyroid hormone and coronary artery disease: from clinical correlations to prognostic implications. Clin Cardiol 2009; 7: 380-385. [CrossRef]
23. Jung CH, Rhee EJ, Shin HS, Jo SK, Won JC, Park CY, et al. Higher serum free thyroxine levels are associated with coronary artery disease. Endocr J 2008; 5: 819-826. [CrossRef]